A study involving over 6 million adults in Sweden has demonstrated that artificial intelligence (AI) can effectively identify individuals at higher risk of developing melanoma by analyzing existing healthcare data. The research found that approximately 0.64% of participants developed melanoma over five years. AI models showed a significant improvement in accuracy, predicting melanoma risk at 73%, compared to 64% when using traditional risk factors like age and sex. Notably, some high-risk groups identified by AI had a melanoma risk as high as 33% within five years. This suggests that healthcare systems could benefit from prioritizing screening for these targeted groups, enhancing early detection and resource allocation. While promising, researchers emphasize that further studies and policy considerations are needed before integrating AI-driven risk predictions into routine healthcare. This shift towards personalized cancer prevention represents a significant advancement in utilizing big data for better health outcomes.